Public Outcry Mounts Over Claim Denials
Viral social media posts are highlighting intense public frustration with insurance claim denials. One post detailing a $350k lawsuit after paying $150k/year in premiums gained over 8,000 likes, while another about Cigna denying a claim for a deceased spouse received 56k likes. The sentiment is echoed by Senator Ron Wyden, who criticized the use of AI for bulk denials, framing it as a key pain point for consumers.
The class-action lawsuit against Cigna centers on its "PxDx" algorithm, which allegedly enabled company doctors to deny over 300,000 claims in just two months, spending an average of only 1.2 seconds per case. In March 2025, a U.S. District Judge in California allowed the case to proceed, stating that letting an algorithm make a medical necessity decision that a doctor simply rubber-stamps could be considered an "abuse of discretion." In response to the growing use of such automated systems, Senator Ron Wyden co-introduced the Algorithmic Accountability Act of 2023. The bill would require companies to assess the impacts of their AI on consumers and create new transparency into how automated systems are used for critical decisions involving housing, employment, and credit. The push for automation is industry-wide, with over 85% of insurers now using AI in their claims workflows. While proponents point to efficiency gains, a 2025 American Medical Association survey found that over 60% of physicians fear that payers' use of unregulated AI is leading to an increase in prior authorization denials. Currently, AI in healthcare operates under a patchwork of state laws with no single comprehensive federal framework. In late 2025, the Department of Health and Human Services (HHS) released its AI Strategy, and by February 2026 was actively requesting public input on expediting AI adoption in clinical settings, signaling a move toward more federal involvement. The controversy highlights a critical distinction in AI's application. While insurers use AI-powered analytics within Special Investigations Units (SIU) to detect and prevent fraud, the public backlash focuses on its use to systematically deny claims based on medical necessity without individual physician review.
